Parsed One operational intelligence for time-critical networks, with a global logistics map

OPERATIONAL INTELLIGENCE INSIGHTS

Precision Therapy Air Cargo: A Cold-Chain Booking Checklist

PARSED ONE · COLD CHAIN

Executive summary. IATA’s 2027 Temperature Control Regulations (15th edition) expand precision-therapy booking guidance, including contingency planning and documentation, and update several airline variations. Sponsors, specialty logistics providers and clinical operations teams should use the remaining 2026 preparation window to test who owns booking information, validated transport controls and recovery decisions for their actual products and routes.

What changed in the 2027 IATA guidance?

IATA released its 2027 cargo manuals on September 7, 2026 and published a further overview on November 5, 2026, ahead of the January 1, 2027 update cycle. Its official summary of the 15th-edition Temperature Control Regulations (TCR) identifies expanded booking requirements for Precision Therapy shipments, specifically including contingency planning and documentation. It also notes new precision-therapy guidance, clarification of dry-ice quantity, stronger handling and equipment-integrity provisions, and updated operator variations for six named airlines.

Those are confirmed changes in IATA’s published TCR summary, not evidence that a particular clinical-trial shipment has been delayed, rejected or exposed to a temperature excursion. Nor does the summary, by itself, establish that every biological specimen or investigational product falls under the same airline acceptance category. Applicability depends on the shipment, classification, operator and local requirements.

Who should review the change?

The highest-value review is for sponsors, CROs, cell- and gene-therapy logistics teams, clinical manufacturing partners, specialty couriers, and laboratories whose operations touch temperature-sensitive investigational therapies. A central lab transporting routine diagnostic specimens should not automatically relabel those specimens as precision therapies; it should review the separately applicable study instructions, specimen stability and infectious-substance classification.

Six checks before the next precision-therapy air booking

  1. Define the actual consignment. Record material type, study or manufacturing reference, agreed shipper/consignee roles, temperature range, required delivery window and the person responsible for transport classification. Keep investigational therapy, diagnostic specimen and infectious-substance requirements distinct.
  2. Confirm the airline’s current acceptance conditions. Compare each planned route and operating carrier against the full applicable 2027 TCR and the carrier’s own procedures. IATA lists updated variations for American Airlines, British Airways, China Airlines, Aer Lingus, Iberia and LEVEL; the summary does not specify that every route on those carriers has changed in the same way.
  3. Validate the booking data package. Agree with the forwarder what documents, handling instructions, contacts and contingency decisions must be present before tender. Test what happens if a data field is incomplete or acceptance is deferred.
  4. Verify the thermal design and handoffs. Confirm qualified packaging or equipment for the actual route, expected dwell times, ground handling and storage. Where dry ice is used, confirm quantity, replenishment and carriage conditions with qualified personnel; do not infer a universal new dry-ice limit from IATA’s high-level summary.
  5. Pre-authorize realistic recovery choices. Define who may approve an alternate flight, qualified holding site or return-to-origin, and who makes the product-quality decision if temperature or time limits are challenged. Make weekend and after-hours contacts testable.
  6. Run a documented exception drill. Simulate missed airline acceptance after collection or manufacture. Capture physical custody, temperature evidence, next confirmed lift, approved product disposition and the closure record—not just a dashboard alert.

A practical separation: shipping rules versus quality decisions

Airline booking acceptance and product quality are related but different controls. An accepted booking does not replace study-specific stability assessment; an alert about airport capacity does not prove an excursion. Build a handoff record that distinguishes verified carrier facts, possible operational exposure and quality decisions made by an authorized study or manufacturer representative. This is a recommended operating practice, not a claim that IATA mandates this exact checklist.

For the broader changes to UN 3373 documentation and infectious-substance transport, read our earlier 2027 specimen shipping readiness guide. This checklist instead focuses on precision-therapy bookings, ground handoffs and cold-chain recovery ownership.

Primary sources

Turn new transport guidance into testable operations

Parsed One helps teams follow relevant disruption and regulatory intelligence for time-sensitive logistics. For clinical-trial sponsors and central-lab operations teams, explore our clinical-trial logistics demo to discuss practical visibility and exception workflows.

Research checked November 15, 2026. This operational planning article does not replace the full current IATA manuals, applicable law, carrier acceptance requirements, qualified shipping advice or product-specific quality procedures.

Save to list